HCA · HCA Healthcare Q2 FY2026 earnings call record财报电话会记录

“Before I get to those, I do want to indicate that the company had solid diluted earnings per share growth of 11% in the quarter and 11% year to date.”

“We had three of our 15 domestic divisions that had outsized effects from this payer mix shift, and they accounted for around 50% of the company's overall impact.”

“Insured volumes, excluding exchanges, across many of our services were solid, with improving trends over the course of the first six months.”

“With respect to surgery volumes, the primary explanation for the decline was from reduced demand in elective surgeries across both inpatient and outpatient settings.”

“We expect to use our cash flow and balance sheet strength to invest further in our business while also returning capital to our shareholders through our capital allocation plans.”

“This one for one migration makes up approximately 80% of our uninsured volume growth, with the remaining 20% related to a decrease in Medicaid conversions, mostly in Texas, which has had a modest financial impact.”

“When we consider the impacts of the exchanges, Medicaid supplemental payment programs, and the impact from the respiratory season and winter storm in the first quarter, our year-to-date operational performance has moderated from our 2025 growth and our initial guidance assumptions.”

“Our revised guidance in 2026 is more in line with our long-term Adjusted EBITDA growth rate target of 4%-6%.”

“Additionally, we purchased $2.1 billion of our outstanding shares, and we paid $171 million in dividends for the quarter.”

“We are maintaining our stated CapEx range of $5 billion-$5.5 billion, and currently plan to complete most of the existing authorized share repurchase program, subject to market conditions and other factors.”

“In our pipeline, we have another 250 to 300 outpatient facilities, either in our capital plan or in our acquisition plans that will come online, we believe, sometime later this year and early next year.”

“About 20% of that growth in our uninsured volume to prior year is coming from this slowdown in Medicaid conversions.”